denotes HDMA members-only content. Join today.

Food and Drug Administration (FDA)

• HDMA Written Comments Following-Up on FDA's REMS Public Meeting - August 31, 2010
• HDMA Statement for the FDA REMS Public Meeting - July 27, 2010
• HDMA Comments on FDA's Transparency Initiative - July 20, 2010
• HDMA Comments on the Unique Device Identifier - September 18, 2009
• Cover Letter to HDMA Comments to FDA on the REMS for Certain Opioids - June 30, 2009
• HDMA Comments on the FDA REMS for Certain Opioids - June 30, 2009
• HDMA Comments to FDA and OMB on MedGuide Paperwork Requirements - December 23, 2008
• HDMA Comments on REMS Under FDAAA - September 22, 2008
• HDMA Public Comments on the draft FDA Five-Year Plan for PDUFA Implementation - June 20, 2008
• HDMA Testimony at Joint FDA Advisory Committee Meeting on iPLEDGE - August 1, 2007
• HDMA Written Comments on Risk Minimization Action Plans (RiskMAPs) - July 27, 2007
• Distributors' Perspective on the Implementation of Risk Minimization Action Plans (RiskMAPs) - June 25, 2007
• HDMA Written Comments on Electronic Prescribing Information - June 22, 2007
• HDMA Testifies at FDA's MedGuide Hearing 6-13-07 - June 18, 2007
• HDMA Testifies on Electronic Prescribing Information Distribution - April 27, 2007
• Agenda for the FDA Public Hearing on Electronic Prescribing Information - April 27, 2007
• HDMA Comments on the Proposed NDC Rule - January 26, 2007
• HDMA Testimony on FDA's Proposed NDC Rule - December 11, 2006
• Patient Safety Implications on Implementation of the Current FDA-Mandated Medication Guide Program - June 27, 2006

Consumer Product Safety Commission (CPSC)

• HDMA Comments on Section 102 of the CPSIA - October 29, 2008
• Coalition Comment Letter on CPSIA - October 29, 2008
• Coalition Meeting Request with the CPSC - October 29, 2008

Centers for Medicare and Medicaid Services (CMS)

• HDMA Policy Position on Congressional Proposals to Preserve Community Pharmacies, Patient Access to Care and Appropriate Use of Generic Medicines Under the Medicaid Program - October 1, 2007
• HDMA Statement on CMS’s Final Rule on AMP - July 17, 2007
• HDMA Public Comments on the Proposed AMP Rule - February 20, 2007

Department of Defense (DoD)

• HDMA Comment Letter to DoD on DFARS Rule - July 18, 2006
  

Environmental Protection Agency (EPA)

• HDMA Comments on EPA Proposed Rule on Pharmaceutical Waste - February 27, 2009

The Office of Mangement and Budget

• HDMA Comments to OMB on Federal Regulatory Review - March 31, 2009

Occupational Safety and Health Administration

• Modernization of OSHA's Injury and Illness Data Collection Process - June 17, 2010
• HDMA Comments on OSHA's MSD Column Reporting/Recordkeeping Proposed Rule - March 29, 2010

U. S. Pharmacopeia

• Cover Letter to HDMA Comments to USP on <1079> Good Storage and Shipping Practices - April 8, 2010
• HDMA Comments on the draft USP Storage and Shipping guidance - April 8, 2010

Contacts
Anita Ducca
Senior Director, Regulatory Affairs
703-885-0240
aducca@hdmanet.org